5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.49▲ | 9.46▲ | 9.46▲ | 9.29▲ | 8.99▲ |
MA10 | 9.43▲ | 9.41▲ | 9.39▲ | 9.12▲ | 9.27▲ |
MA20 | 9.41▲ | 9.28▲ | 9.26▲ | 8.99▲ | 10.28▼ |
MA50 | 9.24▲ | 9.10▲ | 9.09▲ | 9.31▲ | 10.90▼ |
MA100 | 9.12▲ | 9.04▲ | 9.11▲ | 10.50▼ | 12.63▼ |
MA200 | 9.22▲ | 9.38▲ | 9.42▲ | 11.00▼ | 12.97▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | 0.023▲ | 0.027▲ | 0.098▲ | -0.070▼ |
RSI | 67.492▲ | 69.781▲ | 70.351▲ | 61.100▲ | 43.464▼ |
STOCH | 79.630 | 89.429▲ | 90.321▲ | 65.164 | 32.658 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -13.776▲ | -38.313 |
CCI | 130.405▲ | 125.135▲ | 121.617▲ | 140.427▲ | -3.243 |
Thursday, May 16, 2024 07:51 AM
Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead ...
|
Thursday, May 16, 2024 07:32 AM
Blackstone (NYSE: BX) has announced the launch of the Blackstone Life Sciences portfolio company Uniquity Bio, a clinical-stage drug developer on immunology and inflammation.
|
Wednesday, May 15, 2024 11:47 AM
Massachusetts-based private equity firm Blackstone Life Sciences said Wednesday it has committed up to $300 million for a new Chester County biopharmaceutical company developing treatments for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 9.32 | 9.535 | 9.32 | 9.535 | 12,631 |
15/05/24 | 9.50 | 9.67 | 9.32 | 9.39 | 9,782 |
14/05/24 | 9.2019 | 9.445 | 9.10 | 9.41 | 18,809 |
13/05/24 | 9.07 | 9.07 | 9.07 | 9.07 | 16,316 |
10/05/24 | 9.01 | 9.18 | 8.80 | 9.05 | 24,722 |
09/05/24 | 9.00 | 9.28 | 9.00 | 9.13 | 18,705 |
08/05/24 | 8.84 | 9.075 | 8.84 | 8.99 | 31,938 |
07/05/24 | 9.00 | 9.26 | 8.82 | 8.95 | 47,963 |
06/05/24 | 9.00 | 9.2794 | 8.95 | 8.95 | 9,486 |
03/05/24 | 9.236 | 9.31 | 8.69 | 8.75 | 36,968 |
|
|
||||
|
|
||||
|
|